Loading...
Loading IPO details...
CURIS
LISTEDInvestors can bid for minimum 1000 shares (2 lots min for Individual) and in multiples. The table shows min-max investment by Individual and HNI.
| Application | Lots | Shares | Amount |
|---|---|---|---|
Individual(min) | 2 | 2,000 | ₹2.56L |
Individual(max) | 2 | 2,000 | ₹2.56L |
SHNI(min) | 3 | 3,000 | ₹3.84L |
SHNI(max) | 7 | 7,000 | ₹8.96L |
BHNI(min) | 8 | 8,000 | ₹10.24L |
Note: Lot size is 1000 shares at ₹128/share (₹₹1.28L/lot). SME: 2 lots minimum. Limits: Individual ₹0-₹2L, sHNI ₹2L-₹10L, bHNI >₹10L.
Curis Lifesciences Limited is a pharmaceutical company engaged in contract manufacturing and brand marketing for both domestic and international markets, mainly serving clients on loan licenses and contract basis, with exports primarily to Yemen and Kenya. The company operates a single facility in Gujarat and has shown strong growth in revenue and profitability in recent years. For FY25, revenue rose by 38% to ₹49.6 crore, and profit after tax increased by 25% to ₹6.1 crore.[web:1][web:3][web:5][web:7][web:9]
Curis Lifesciences offers compelling growth, healthy financials, and is fairly valued based on SME benchmarks. However, operational, regulatory, and concentration risks remain significant for long-term holding. Given the robust oversubscription and positive GMP, there is a good likelihood of listing gains; thus, consider applying for short-term profits rather than long-term investment.[web:2][web:4][web:8]
Analyst Notes: Automated research generated via Perplexity AI